Type Public Products Pharmaceuticals Website Website Parent organization Bristol-Myers Squibb | Key people Stephanie Feldt Owner Bristol-Myers Squibb Founded 1981 | |
 | ||
Industry Biotechnology/Pharmaceuticals Founders Earl W. Davie, Benjamin D. Hall, Michael Smith | ||
Zymogenetics shares up 84 after bristol myers squibb announced it would acquire it for 885 million
ZymoGenetics, Inc is one of the oldest biotechnology/pharmaceutical companies in the USA, based in Seattle, Washington. The company is involved in the development of therapeutic proteins. Located on Lake Union, the address of the ZymoGenetics headquarters is 1201 Eastlake Avenue East.
Contents
- Zymogenetics shares up 84 after bristol myers squibb announced it would acquire it for 885 million
- News update bristol myers squibb announce 800 job cuts
- Corporate governance
- References
The company was founded in 1981 by Professors Earl W. Davie and Benjamin D. Hall of the University of Washington and 1993 Nobel Laureate in Chemistry Michael Smith of the University of British Columbia. Soon after its founding, ZymoGenetics began working on recombinant proteins with Danish company Novo Nordisk, and was acquired by that company in 1988. It was spun off as a public company in 2000. Bristol-Myers Squibb acquired the company in 2010 for $885 million.
ZymoGenetics' headquarters are in the landmark Lake Union Steam Plant building, built from 1914 to 1921 by Seattle City Light, the municipal electric utility.
News update bristol myers squibb announce 800 job cuts
Corporate governance
In late 2013, the company's president, Stephen W. Zaruby, left and took up the president and chief executive officer roles at Aurinia Pharmaceuticals.